Skip to content
Taxonomy
What 50 People Taught Us About CMT1E Progression and Genetics
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
Augustine Therapeutics Begins New CMT Trial
CMT news out of Belgium: Augustine Therapeutics has officially dosed Read More
CMTA-STAR Partner Applied Therapeutics Presents 24-Month CMT-SORD Data at PNS 2025
The Charcot-Marie-Tooth Association (CMTA) congratulates CMTA Strategy To Accelerate Research Read More
CMTA Presents New Genetic Landscape Analysis at The 2025 Annual Meeting of the Peripheral Nerve Society
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth Read More
CMTA-INC Alliance Announces 2025 Inherited Neuropathies Fellowship Recipient
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth Read More
CMTA Announces New Center of Excellence in Cincinnati
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
Could MRI Help Speed Up CMT1A Research? New Findings from Professor Mary M. Reilly, MBE
A newly published study led by CMTA’s Strategy to Accelerate Read More
CMTA Announces New Center of Excellence in Canada
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery
Today, the Charcot-Marie-Tooth Association (CMTA) announced a $210,000 investment to Read More
CMT2F Study Achieves Recruitment Goal, Expands to Include Additional Participants
An international team of researchers from the Inherited Neuropathies Consortium Read More
